Skip to content

Use of a Dietary Supplement to Support Digestive Health in Children With Chronic Diarrhea

Assessment of the Utility of a Dietary Supplement as an Adjunct to Standard of Care for Children With Chronic Diarrhea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02856386
Enrollment
50
Registered
2016-08-04
Start date
2016-08-31
Completion date
2017-05-31
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic-associated Diarrhea

Brief summary

Micronutrients missing in the diet may assist in supporting digestive health in children with chronic GI issues. This study will monitor changes in symptoms associated with digestive problems in children provided with a dietary supplement that will be taken in conjunction with the standard of care.

Detailed description

Children with GI symptoms have varying response to the standard of care treatments. A dietary supplement of polyphenols from green tea and pomegranate extracts provides micronutrients often missing from conventional American diets. The objective of this study is to monitor changes in GI symptoms when the supplement is provided alongside the standard of care for children with symptoms that have been present for more than two weeks.

Interventions

DIETARY_SUPPLEMENTpolyphenol supplement

8 mL once daily

Sponsors

LiveLeaf Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 17 Years
Healthy volunteers
No

Inclusion criteria

* Out-patients with diagnosis of unresolved gastrointestinal distress * Parent or guardian willing to administer the dietary supplement orally once daily for up to 21 days * Parent or guardian willing to record changes in GI symptoms on a questionnaire * Parent or guardian willing to bring the child for a clinic visit to close-out participation in the study

Exclusion criteria

* requires care in an ICU * has documented intestinal stricture, stenosis, obstruction, or abscess * has concomitant congenital diseases * are immunodeficient * has malformation of the GI tract * is unable to swallow fluids * parent or guardian is unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frame
Time to resolution of GI symptoms3 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026